Insider Transactions in Q1 2025 at Pfizer Inc (PFE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 04
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
2,500
-17.42%
|
$62,500
$25.93 P/Share
|
|
Mar 04
2025
|
Jennifer B. Damico SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
5,583
+28.01%
|
-
|
|
Feb 27
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
22,296
-24.35%
|
$579,696
$26.09 P/Share
|
|
Feb 27
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
8,909
-5.18%
|
$231,634
$26.1 P/Share
|
|
Feb 27
2025
|
Christoffel Boshoff President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
17,450
+9.2%
|
-
|
|
Feb 27
2025
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
22,416
+41.92%
|
$694,896
$31.31 P/Share
|
|
Feb 27
2025
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
564,155
-30.86%
|
$14,668,030
$26.08 P/Share
|
|
Feb 27
2025
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
582,823
+38.48%
|
$18,067,513
$31.31 P/Share
|
|
Feb 27
2025
|
Lidia Fonseca Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
69,705
-31.72%
|
$1,812,330
$26.08 P/Share
|
|
Feb 27
2025
|
Lidia Fonseca Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
72,629
+39.44%
|
$2,251,499
$31.31 P/Share
|
|
Feb 27
2025
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
150,550
-24.58%
|
$3,914,300
$26.08 P/Share
|
|
Feb 27
2025
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
156,914
+33.62%
|
$4,864,334
$31.31 P/Share
|
|
Feb 27
2025
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
46,455
-19.14%
|
$1,207,830
$26.08 P/Share
|
|
Feb 27
2025
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
48,419
+28.34%
|
$1,500,989
$31.31 P/Share
|
|
Feb 27
2025
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,314
-20.91%
|
$476,164
$26.08 P/Share
|
|
Feb 27
2025
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
19,054
+30.1%
|
$590,674
$31.31 P/Share
|
|
Feb 27
2025
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
81,957
-16.47%
|
$2,130,882
$26.08 P/Share
|
|
Feb 27
2025
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
85,182
+25.35%
|
$2,640,642
$31.31 P/Share
|
|
Feb 26
2025
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,220
-4.17%
|
$83,720
$26.42 P/Share
|
|
Feb 26
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
4,872
-3.05%
|
$126,672
$26.42 P/Share
|
|
Feb 26
2025
|
Christoffel Boshoff President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
9,687
+5.71%
|
-
|
|
Feb 23
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-4.14%
|
$10,140
$26.3 P/Share
|
|
Feb 23
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.44%
|
$17,212
$26.3 P/Share
|
|
Feb 22
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
8,188
-23.76%
|
$212,888
$26.19 P/Share
|
|
Feb 22
2025
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,741
+33.18%
|
$262,230
$30.17 P/Share
|
|
Feb 22
2025
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,422
-5.98%
|
$270,972
$26.19 P/Share
|
|
Feb 22
2025
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,125
+11.26%
|
$333,750
$30.17 P/Share
|
|
Feb 22
2025
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
79,899
-17.4%
|
$2,077,374
$26.19 P/Share
|
|
Feb 22
2025
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
85,824
+26.94%
|
$2,574,720
$30.17 P/Share
|
|
Feb 22
2025
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
221,515
-19.71%
|
$5,759,390
$26.19 P/Share
|
|
Feb 22
2025
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
238,399
+29.47%
|
$7,151,970
$30.17 P/Share
|
|
Feb 22
2025
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
59,500
-13.37%
|
$1,547,000
$26.19 P/Share
|
|
Feb 22
2025
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
63,573
+22.02%
|
$1,907,190
$30.17 P/Share
|
|
Feb 22
2025
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,911
-16.29%
|
$309,686
$26.19 P/Share
|
|
Feb 22
2025
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,714
+25.52%
|
$381,420
$30.17 P/Share
|
|
Feb 22
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
8,138
-2.56%
|
$211,588
$26.19 P/Share
|
|
Feb 22
2025
|
Christoffel Boshoff President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,741
+5.21%
|
$262,230
$30.17 P/Share
|
|
Feb 13
2025
|
Ronald E Blaylock Director |
BUY
Open market or private purchase
|
Direct |
19,457
+41.25%
|
$486,425
$25.65 P/Share
|
|
Jan 31
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
12,038
-7.41%
|
$312,988
$26.52 P/Share
|